-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Propanc Biopharma, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2011 to 2024.
- Propanc Biopharma, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$275.000, a 84% increase year-over-year.
- Propanc Biopharma, Inc. annual Income Tax Expense (Benefit) for 2024 was -$129K, a 0.55% increase from 2023.
- Propanc Biopharma, Inc. annual Income Tax Expense (Benefit) for 2023 was -$130K, a 136% decline from 2022.
- Propanc Biopharma, Inc. annual Income Tax Expense (Benefit) for 2022 was -$55K, a 51.5% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)